Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the Clinic

por Kumar, Sanjeev, Freelander, Allegra, Lim, Elgene
Publicado 2021

CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective

por Zhou, Fiona H., Downton, Teesha, Freelander, Allegra, Hurwitz, Joshua, Caldon, C. Elizabeth, Lim, Elgene
Publicado 2023

Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer

por Freelander, Allegra, Brown, Lauren J., Parker, Andrew, Segara, Davendra, Portman, Neil, Lau, Brandon, Lim, Elgene
Publicado 2021